Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
about
An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptorThe envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.Visualization of targeted transduction by engineered lentiviral vectorsAssessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors.The role of matrix in HIV-1 envelope glycoprotein incorporationSelective lentiviral gene delivery to CD133-expressing human glioblastoma stem cellsMembrane-anchored peptide inhibits human immunodeficiency virus entry.Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.Molecular engineering of viral gene delivery vehiclesFunctional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectorsAdaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range.Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cellsCapsid is a dominant determinant of retrovirus infectivity in nondividing cells.Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cellsIn vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles.The prM-independent packaging of pseudotyped Japanese encephalitis virusHSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.Gene therapy for transplantation with viral vectors--how much of the promise has been realised?Spontaneous heteromerization of gammaretrovirus envelope proteins: a possible novel mechanism of retrovirus restrictionTargeted cell entry of lentiviral vectors.Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles.Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.Mechanisms for Env glycoprotein acquisition by retroviruses.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Drug target discovery using retroviruses.Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.Engineered retroviral virus-like particles for receptor targeting.Incorporation of wild-type and C-terminally truncated human epidermal growth factor receptor into human immunodeficiency virus-like particles: insight into the processes governing glycoprotein incorporation into retroviral particles.Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles.Lipid rafts and pseudotyping.Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites.Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.Development of a Moloney murine leukemia virus-based pseudotype anti-HIV assay suitable for accurate and rapid evaluation of HIV entry inhibitors.Development of a novel dual CCR5-dependent and CXCR4-dependent cell-cell fusion assay system with inducible gp160 expression.Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles
P2860
Q24524784-76CAD965-89D9-4F49-819E-53625BFC9D96Q24537689-57137057-0C0C-42F4-A3B3-2912F9DC18DEQ24646930-24EDF671-C199-42CD-B231-2E4E7F074DD5Q24814516-2625118E-6C89-4D3C-BDC7-40C1EE231E81Q27023106-6987BB6B-4736-44DC-BA59-96315972749DQ27318247-975667E8-101D-4AFB-AD9D-AC0915142B57Q28354004-6B586961-1D75-408A-AEF5-00E11F116EEAQ31115300-59AAB466-FFF4-4A8D-AC21-D66C07030B3DQ33353795-9F6ADDBD-C860-431A-8B65-3530DCCA6027Q33737672-CB950FB2-843A-4BEB-A70E-D29C1EE5F086Q33839293-D20A9391-290D-4043-A915-E442A37A1C9FQ33851610-86B992C4-9FB9-4941-970A-9D70E2280EF6Q33953076-12CEAC66-9713-4ECC-9B8C-4A3A5FA28174Q34152408-27270BF7-B105-45A2-B6A4-ACE2E091D396Q34326352-599FCFCA-80BF-42BA-B84F-41EDDF848E82Q34344453-9EFCB30B-2ECE-45BC-8550-35AF348FA09BQ34439347-17EA2B00-67CC-4EDD-A9DB-996A738B2C29Q35181739-62BEF787-FF66-4D4A-A3DD-70C417A949CCQ35575383-27A76950-D593-4EFC-A673-5549739DEBF7Q35585672-328814F1-F850-45F0-A2C5-D75C4221BC0AQ36315018-59350FCC-0273-418C-850B-B44EF3CBFC01Q36541946-63EE3321-0620-4017-BF97-8F43AE70E57FQ36898828-028F0642-71C2-42EE-8029-D59AAC4E66D9Q37589994-BF4FE5A9-DD8E-4D55-BC73-E8969385D7E0Q37701191-6193820C-4975-4E23-A747-4C0C3A5E4A74Q37782256-720C8342-B703-478E-89F7-FB8D7F564138Q37830047-93D8C3CD-9E0F-4383-9557-C30AE51EFA9CQ37896455-AFE8661A-0E2C-463D-A20E-0645882CBB3BQ38088729-469D0339-E5E6-419E-B863-C9F5739976C7Q38123692-A624541B-0F5F-43C2-B9DC-A46C0797AAC2Q39077630-2D64B872-609A-4855-820F-B46B9DCFB740Q39596501-BBD53BD2-BA99-405E-8840-7103C56214FAQ39601359-4585A41A-1B6C-4741-943C-A85F22DA5BD0Q39603900-10381807-424C-4EAF-A2C5-4B28FD917908Q39676464-232ED1ED-3781-4C2F-9B6C-6FFF861C41B7Q39756385-8B65A648-EB51-4237-9574-DF542173B777Q40255176-CC94A80C-5BAB-4E9B-8294-3ADAE28C8F67Q40346497-793F245B-C672-43C2-A0D3-C02D8184FA7DQ40785389-4B50CEBA-5D13-4784-9132-1725A826DD3EQ41894731-2C461313-3E12-4A7F-875D-05230B3299E1
P2860
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@ast
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@en
type
label
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@ast
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@en
prefLabel
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@ast
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@en
P2093
P2860
P356
P1476
Pseudotyping of murine leukemi ...... tion for CD4-expressing cells.
@en
P2093
Cichutek K
Engelstädter M
Merget-Millitzer H
Schnierle BS
P2860
P304
P356
10.1073/PNAS.94.16.8640
P407
P577
1997-08-01T00:00:00Z